• Careers
  • Support



The HPAEC-BMI1 are primary human pulmonary endothelial cells that were immortalized using B Lymphoma Mo-MLV Insertion Region 1 (BMI1). This cell line can be used to investigate the pathogenesis of cardiovascular disease, pulmonary hypertension, or discover and develop anti- and pro-angiogenic compounds.
Product category
Human cells
Product type
Cell model
hTERT-immortalized cell
Homo sapiens, human
Cell type
endothelial cell
Pulmonary artery
Cancer research
Cardiovascular disease research
Drug development
Product format
Storage conditions
Vapor phase of liquid nitrogen
Buy Now
Price: $6,256.00 ea
Discounts may be available for our fellow nonprofit organizations. Login to see your price.

Generally ships within 1-3 business days


ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.

ATCC highly recommends that appropriate personal protective equipment is always used when handling vials. For cultures that require storage in liquid nitrogen, it is important to note that some vials may leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vial exploding or blowing off its cap with dangerous force creating flying debris. Unless necessary, ATCC recommends that these cultures be stored in the vapor phase of liquid nitrogen rather than submersed in liquid nitrogen.

Required Products

These products are vital for the proper use of this item and have been confirmed as effective in supporting functionality. If you use alternative products, the quality and effectiveness of the item may be affected.

Detailed product information


Specific applications
Cardiovascular disease research, angiogenesis studies, drug discovery and development, high throughput screening


Cells per vial
≥ 1.0 x 106
1.0 mL
Growth properties
Near-diploid, human male karyotype

HPAEC-BMI1 is a clonal cell line immortalized by stably expressing human BMI1 gene in primary pulmonary artery endothelial cells. 

The cells should be maintained in blasticidin (4 µg/mL) containing medium in routine cell culture.

Similar to hTERT immortalization techniques, BMI1-immortalized cells typically demonstrate the physiological characteristics of their parental primary cells. HPAEC-BMI1 cells retain important endothelial cell characteristics and functions such as express CD31/ PECAM-1, uptake acetylated low density lipoprotein (AcLDL), and form capillary-like tubes on a basement membrane matrix.

Handling information

Complete medium

The base medium for this cell line is Vascular Cell Basal Medium (ATCC PCS-100-030). To make the complete growth medium, add the following components to the base medium:

95% Air, 5% CO2
Handling procedure

To ensure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C.  Storage at -70°C will result in loss of viability.  

  1. Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water.  Thawing should be rapid (approximately 2 minutes).
  2. Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.
  3. Transfer the vial contents to a centrifuge tube containing  9.0 mL complete culture medium. and spin at approximately 220 x g for 5 minutes.
  4. Resuspend cell pellet with the recommended complete medium (see the specific batch information for the culture recommended dilution ratio). It is important to avoid excessive alkalinity of the medium during recovery of the cells.  It is suggested that, prior to the addition of the vial contents, the culture vessel containing the complete growth medium be placed into the incubator for at least 15 minutes to allow the medium to reach its normal pH (7.0 to 7.6). pH (7.0 to 7.6).
  5. Incubate the culture at 37°C in a suitable incubator.  A 5% CO2 in air atmosphere is recommended if using the medium described on this product sheet.


Subculturing procedure
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product.
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with D-PBS (ATCC 30-2200) to remove all traces of serum that contains trypsin inhibitor.
  3. Add 3.0 to 4.0 mL of Trypsin-EDTA for Primary Cells solution (ATCC PCS-999-003) to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Once detached, add 3.0 to 4.0 mL of Trypsin Neutralizing Solution (ATCC PCS-999-004) and aspirate cells by gently pipetting. Transfer cell suspension into a 15mL conical tube.
  5. Collect cells by centrifugation at 220 x g for 5 minutes. Discard the supernatant.
  6. Resuspend cell pellet in 6.0 to 8.0 mL complete medium. Add appropriate aliquots of the cell suspension to new culture vessels.
    Cultures can be established between 4 x 103 and 5 x 103 viable cells/cm2.
  7. Incubate cultures at 37°C.
Interval: Maintain cultures at a cell concentration between 4 X 103 and 3.8 X 104 cell/cm2.
Subcultivation Ratio: A subcultivation ratio of 1:5 to 1:9 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation Stem Cell Freezing Media (ATCC ACS-3020)

Quality control specifications

Bacterial and fungal testing
Not detected
Mycoplasma contamination
Not detected
Functional tests
Telomerase Activity (TRAP Assay): Positive, ≥ 4 repeats
FACS Analysis: Positive for CD31/ PECAM-1
AcLDL Uptake: Capable of uptaking AcLDL
Population doubling time
Approximately 30 hrs
STR profiling
Amelogenin: X,Y
CSF1PO: 10
D13S317: 11,12
D16S539: 9,12
D5S818: 12
D7S820: 7
THO1: 9.3
TPOX: 11
vWA: 17,18


Year of origin

Legal disclaimers

Intended use
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.

The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid.  Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.


This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.

While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.

This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.

Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at

Permits & Restrictions

Material Transfer Agreement Addendum for Screening Applications

For-profit organizations
For every order of this item, you must provide a signed Material Transfer Agreement Addendum for Screening Applications. We cannot ship this item until we receive this addendum. The person signing the addendum as the principal investigator must match the end user as listed on the applicable sales order for the item.

Email the signed addendum to [email protected] with a reference to both your account and sales order numbers. Once received, your addendum will be reviewed, and this item will be released for shipment if all requirements are met. Additional fees may apply if this product is being used for a screening use (ATCC ACS-2103F), and these fees will be applied after your order is confirmed. If you need assistance with your order, please contact our Customer Care team or your applicable distributor.



Curated Citations

GP Dimri, et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62(16): 4736-45, 2002. PubMed: 12183433

CE Evans, et al. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 58(3):2003957, 2021. PubMed: 33509961

K Sobierajska, et al. Endothelial Cells in the Tumor Microenvironment. Adv Exp Med Biol 1234: 71-86, 2020. PubMed: 32040856

C Viallard, et al. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20(4): 409-426, 2017. PubMed: 28660302

A Eckers, et al. Endothelial cells in health and disease. Antioxid Redox Signal 22(14): 1209-11, 2015. PubMed: 25758789

Frequently Asked Questions

Need assistance with this product? Contact our Technical Support team.


US and Puerto Rico

Outside the US

Hours of Operation

9:00am - 5:00pm
US Eastern Time